Related Experiment Video
Updated: Feb 11, 2026

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
Published on: May 17, 2019
Extrinsic Phagocyte-Dependent STING Signaling Dictates the Immunogenicity of Dying Cells
Jeonghyun Ahn1, Tianli Xia1, Ailem Rabasa Capote1
1Department of Cell Biology, The University of Miami Miller School of Medicine, University of Miami, 511 Papanicolaou Building, 1550 NW 10th Avenue, Miami, FL 33136, USA.
Abstract:
The ability of dying cells to activate antigen-presenting cells (APCs) is carefully controlled to avoid unwarranted inflammatory responses. Here, we show that engulfed cells containing cytosolic double-stranded DNA species (viral or synthetic) or cyclic di-nucleotides (CDNs) are able to stimulate APCs via extrinsic STING (stimulator of interferon genes) signaling, to promote antigen cross-presentation. In the absence of STING agonists, dying cells were ineffectual in the stimulation of APCs in trans. Cytosolic STING activators, including CDNs, constitute cellular danger-associated molecular patterns (DAMPs) only generated by viral infection or following DNA damage events that rendered tumor cells highly immunogenic. Our data shed insight into the molecular mechanisms that drive appropriate anti-tumor adaptive immune responses, while averting harmful autoinflammatory disease, and provide a therapeutic strategy for cancer treatment.
Insights
Dying cells activate antigen-presenting cells (APCs) through STING signaling when containing cytosolic DNA or cyclic di-nucleotides (CDNs). This mechanism promotes anti-tumor immunity and avoids harmful inflammation, offering a cancer treatment strategy.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- Antigen-presenting cells (APCs) activation by dying cells is tightly regulated to prevent excessive inflammation.
- Uncontrolled inflammation can lead to autoimmune diseases, while insufficient immune responses impair anti-tumor activity.
Purpose of the Study:
- To elucidate the molecular mechanisms by which dying cells stimulate APCs for effective anti-tumor immunity.
- To identify the role of cytosolic DNA and cyclic di-nucleotides (CDNs) in APC activation.
- To explore the STING (stimulator of interferon genes) pathway's involvement in this process.
Main Methods:
- Investigated the role of cytosolic double-stranded DNA and CDNs in stimulating APCs.
- Utilized STING signaling pathway agonists and antagonists.
- Assessed the impact of these factors on antigen cross-presentation by APCs.
Main Results:
- Engulfed cells with cytosolic DNA or CDNs activate APCs via extrinsic STING signaling.
- STING agonists are essential for dying cells to stimulate APCs in trans.
- Cytosolic STING activators act as danger-associated molecular patterns (DAMPs) during viral infection or DNA damage.
Conclusions:
- Cytosolic STING activators are key mediators linking dying cells to APC stimulation and anti-tumor immunity.
- This pathway promotes immunogenic tumor cell death and adaptive immune responses.
- Understanding this mechanism offers a potential therapeutic strategy for cancer treatment by enhancing anti-tumor immunity.
More Related Videos
Related Concept Videos
Contact-dependent Signaling
Gap Junctions
In animal cells, gap junctions are formed...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
What is Cell Signaling?
The Extrinsic Apoptotic Pathway
Kubler Ross's Stages of Dying
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from...

